Novel role of NLRP3-inflammasome in regulation of lipogenesis in fasting-induced hepatic steatosis
Baoqing Liu,1 Xiaoxiang Mao,2,3 Dandan Huang,2,3 Fei Li,1 Nianguo Dong11Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Department of Cardiology, Union Hospital, Tongji Medical...
Enregistré dans:
Auteurs principaux: | Liu B, Mao X, Huang D, Li F, Dong N |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5b37ca73dbc0437a8b6f58ee6a1b66fe |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
par: Zhang C, et autres
Publié: (2019) -
NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
par: Wan Z, et autres
Publié: (2019) -
Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
par: Choudhury SM, et autres
Publié: (2021) -
Spotlight on the NLRP3 inflammasome pathway
par: Groslambert M, et autres
Publié: (2018) -
Jinmaitong Ameliorates Diabetic Peripheral Neuropathy Through Suppressing TXNIP/NLRP3 Inflammasome Activation In The Streptozotocin-Induced Diabetic Rat Model
par: Sun Q, et autres
Publié: (2019)